Cargando…

Peripheral T cell lymphoma coexisting with Castleman's disease: A case report and literature review

RATIONALE: Peripheral T cell lymphoma, coexisting with Castleman's disease (CD), is rarely seen in clinical practice and is not frequently reported in the literature. PATIENT CONCERNS: A 68-year-old female was admitted to our hospital for the first time due to “multiple lumps in the neck that p...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shuyan, Wang, Yuanwen, Hu, Tonglin, Zhang, Chunli, Zheng, Zhiyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959880/
https://www.ncbi.nlm.nih.gov/pubmed/31914048
http://dx.doi.org/10.1097/MD.0000000000018650
_version_ 1783487670507274240
author Liu, Shuyan
Wang, Yuanwen
Hu, Tonglin
Zhang, Chunli
Zheng, Zhiyin
author_facet Liu, Shuyan
Wang, Yuanwen
Hu, Tonglin
Zhang, Chunli
Zheng, Zhiyin
author_sort Liu, Shuyan
collection PubMed
description RATIONALE: Peripheral T cell lymphoma, coexisting with Castleman's disease (CD), is rarely seen in clinical practice and is not frequently reported in the literature. PATIENT CONCERNS: A 68-year-old female was admitted to our hospital for the first time due to “multiple lumps in the neck that progressively enlarged over 7 months”. 1.5 years later, the patient returned to our hospital complaining of “ difficulty breathing and purulent blood in the mouth for more than 20 days”. DIAGNOSIS: The postoperative pathology from the (right) cervical lymph node biopsy confirmed the diagnosis of Castleman Disease (Vascular follicular type). 1.5 years after the diagnosis of CD, the patient developed secondary peripheral T cell lymphoma of unspecified type (PTCL-U). INTERVENTIONS: The patient received 5 courses of chemotherapy: 2 courses of CHOP, Chidamide combined with GemOx, GDP and Hyper CVAD Bregimen. OUTCOMES: After 3 courses of treatment, the curative effect was partly remitted (PR). The patient was discharged in a good condition and the follow-up was uneventful. LESSONS: The mechanism responsible for CD concurrent or secondary lymphoma is not clear. Epstein-Barr virus (EBV) infection may be the most common reason of CD and PTCL-U. Further understanding the mechanisms of the condition is needed.
format Online
Article
Text
id pubmed-6959880
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-69598802020-01-31 Peripheral T cell lymphoma coexisting with Castleman's disease: A case report and literature review Liu, Shuyan Wang, Yuanwen Hu, Tonglin Zhang, Chunli Zheng, Zhiyin Medicine (Baltimore) 4800 RATIONALE: Peripheral T cell lymphoma, coexisting with Castleman's disease (CD), is rarely seen in clinical practice and is not frequently reported in the literature. PATIENT CONCERNS: A 68-year-old female was admitted to our hospital for the first time due to “multiple lumps in the neck that progressively enlarged over 7 months”. 1.5 years later, the patient returned to our hospital complaining of “ difficulty breathing and purulent blood in the mouth for more than 20 days”. DIAGNOSIS: The postoperative pathology from the (right) cervical lymph node biopsy confirmed the diagnosis of Castleman Disease (Vascular follicular type). 1.5 years after the diagnosis of CD, the patient developed secondary peripheral T cell lymphoma of unspecified type (PTCL-U). INTERVENTIONS: The patient received 5 courses of chemotherapy: 2 courses of CHOP, Chidamide combined with GemOx, GDP and Hyper CVAD Bregimen. OUTCOMES: After 3 courses of treatment, the curative effect was partly remitted (PR). The patient was discharged in a good condition and the follow-up was uneventful. LESSONS: The mechanism responsible for CD concurrent or secondary lymphoma is not clear. Epstein-Barr virus (EBV) infection may be the most common reason of CD and PTCL-U. Further understanding the mechanisms of the condition is needed. Wolters Kluwer Health 2020-01-10 /pmc/articles/PMC6959880/ /pubmed/31914048 http://dx.doi.org/10.1097/MD.0000000000018650 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4800
Liu, Shuyan
Wang, Yuanwen
Hu, Tonglin
Zhang, Chunli
Zheng, Zhiyin
Peripheral T cell lymphoma coexisting with Castleman's disease: A case report and literature review
title Peripheral T cell lymphoma coexisting with Castleman's disease: A case report and literature review
title_full Peripheral T cell lymphoma coexisting with Castleman's disease: A case report and literature review
title_fullStr Peripheral T cell lymphoma coexisting with Castleman's disease: A case report and literature review
title_full_unstemmed Peripheral T cell lymphoma coexisting with Castleman's disease: A case report and literature review
title_short Peripheral T cell lymphoma coexisting with Castleman's disease: A case report and literature review
title_sort peripheral t cell lymphoma coexisting with castleman's disease: a case report and literature review
topic 4800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959880/
https://www.ncbi.nlm.nih.gov/pubmed/31914048
http://dx.doi.org/10.1097/MD.0000000000018650
work_keys_str_mv AT liushuyan peripheraltcelllymphomacoexistingwithcastlemansdiseaseacasereportandliteraturereview
AT wangyuanwen peripheraltcelllymphomacoexistingwithcastlemansdiseaseacasereportandliteraturereview
AT hutonglin peripheraltcelllymphomacoexistingwithcastlemansdiseaseacasereportandliteraturereview
AT zhangchunli peripheraltcelllymphomacoexistingwithcastlemansdiseaseacasereportandliteraturereview
AT zhengzhiyin peripheraltcelllymphomacoexistingwithcastlemansdiseaseacasereportandliteraturereview